Who Paid My Doc
Janine Forche
Physician Assistant, Medical Lambertville, MI Physician Assistant
NPI 1023145018 CMS profile 10689246
7581 Secor Rd, Lambertville, MI 48144
General payments
$6,751
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Janine Forche of Lambertville, MI is reported in the CMS Open Payments database as having received $6,751 across 404 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 92nd percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $117 | 6 | |
| 2024 | General | $129 | 8 | |
| 2023 | General | $1,940 | 110 | |
| 2022 | General | $2,502 | 150 | |
| 2021 | General | $2,063 | 130 |
Beside peers
- Janine Forche
- Physician Assistant, Medical median
- Middle half of Physician Assistant, Medical
- National median
In program year 2025, general payments to Janine Forche were reported at $117. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.
Show as a table
| Year | Janine Forche | Physician Assistant, Medical median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $61 | $19–$193 | $163 |
| 2020 | $0 | $20 | $14–$64 | $114 |
| 2021 | $2,063 | $156 | $41–$563 | $132 |
| 2022 | $2,502 | $185 | $55–$649 | $149 |
| 2023 | $1,940 | $199 | $58–$717 | $160 |
| 2024 | $129 | $206 | $62–$740 | $164 |
| 2025 | $117 | $214 | $62–$755 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 128 drugsPart D claims
7,419
Drug cost
$481,089
Branded share of claims
18.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 67 | $72,582 | |
| Eliquis Apixaban | Brand | 60 | $50,644 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 49 | $43,690 | |
| Ozempic Semaglutide | Brand | 33 | $32,350 | |
| Januvia Sitagliptin Phosphate | Brand | 21 | $30,248 | |
| Rybelsus Semaglutide | Brand | 15 | $27,083 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 42 | $26,959 | |
| Mounjaro Tirzepatide | Brand | 16 | $18,782 | |
| Xarelto Rivaroxaban | Brand | 17 | $15,120 | |
| Trulicity Dulaglutide | Brand | 15 | $14,370 |
The 10 drugs with the highest cost, of 128 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 53 billing codesPaid by Medicare
$54,434
Medicare patients
290
Services billed
909
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 64% | |
| Arthritis | 46% | |
| Diabetes | 28% | |
| Ischemic heart disease | 24% | |
| COPD | 22% | |
| Depression | 22% | |
| Chronic kidney disease | 20% | |
| Heart failure | 19% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Pcv20 vaccine im 90677 | Office | 24 | 24 | $6,946 |
| Vaccine for influenza for injection into muscle 90653 | Office | 39 | 39 | $3,191 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
404 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physician Assistant, Medical in Michigan
Caleb Youngblood
Physician Assistant, Medical · Berkley, MI
Steven Stone
Physician Assistant, Medical · Kalamazoo, MI
Meredith Kent
Physician Assistant, Medical · Grand Rapids, MI
Amber Shull
Physician Assistant, Medical · Norton Shores, MI
Jason Evans
Physician Assistant, Medical · Waterford, MI
James Torey
Physician Assistant, Medical · Saint Clair Shores, MI
Related records
Physician Assistant, Medical in Michigan
Practitioners in the same specialty and state, ranked by reported value.
All Physician Assistant, Medical
Everyone recorded under this specialty, nationwide.
Doctors in Michigan
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.